nference
Healthcare Software · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1 Main East St Fl 4 Ste 400, Cambridge, ...Website
www.nference.comRevenue
$104.6 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
3
4
2
2
About nference
Founded in 2013, nference is building a holistic software platform that synthesizes the worlds exponentially-growing and siloed biomedical knowledge. nference uses state-of-the-art neural networks for real-time, automated extraction of insights by triangulating unstructured and structured information from the biomedical literature as well as from large scale molecular and real world datasets. The company is headquartered in Cambridge, Massachusetts.Explore more
nference Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is nference your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on nference recently announced quarterly report
Product Launch: Get notified when nference launches new products
nference, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if nference is spiking on competitors!
Click to see if nference had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if nference has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at nference
Funding: Get notified immidiatlly once nference has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
nference is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
nference is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about nference.
nference financials insights
Gather financial insights about nference, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$11M
2020
Series B
$60M
Series C
$60M
nference Tech Stack
A closer look at the technologies used by nference
Most Recent Scoops
Award
Award, Business Intelligence, Analytics & Insights, Artificial Intelligence, Finance
Event
Events, Engineering, Sales, Learning & Development, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, HR Operations, Operations, Patient Experience
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Left Company
Executive Move
nference News & Media
nference Announces Multi-Year Funding from Global Foundation to Advance Health Equity
CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference announced a multi-year licensing agreement with the Bill & Melinda Gates Foundation to advance health equity.How Is AI Technology Changing The Healthcare Industry And Who Is Leading The Charge?
Nference Inc. is a leading artificial intelligence (AI) company dedicated to transforming the way healthcare is developed and delivered. Founded in 2013 by Murali Aravamudan and Venky Soundararajan, the company is developing a suite of cutting-edge products designed to empower healthcare professionals with the insights and intelligence they need to make better decisions faster. See Next: This Startup Invented Programmable, Drinkable Plastic That Dissolves In Water In 60 Hours Nference’s productsNew nference Study Identifies Distinctive Characteristics of SARS-CoV-2 Variants Using Genomic Diversification
CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference, an AI-driven health technology company, today announced the publication of a preprint study in medRxiv, validating the company’s methodology for characterizing SARS-CoV-2 evolution. The study provides the first compelling genomic signal showing how highly transmissive and immuno-evasive variants, such as Omicron and Delta, emerge as dominant variants of concern. The study, titled “Continuous genomic diversification of long polynucleotide fragments drnference and Mayo Clinic Study Confirms Effectiveness of Moderna and Pfizer/BioNTech Vaccines Against COVID-19 Alpha and Delta Variants
CAMBRIDGE, Mass., Dec. 15, 2021 /PRNewswire/ -- nference, the AI-driven health technology company, announced today publication of a peer-reviewed study in Med that analyzed Mayo Clinic based data with nference artificial intelligence (AI) software to determine that both the Moderna and...
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding nference
Sign Up For FreeTo access detailed company insights
Founded in 2013, nference is building a holistic software platform that synthesizes the worlds exponentially-growing and siloed biomedical knowledge. nference uses state-of-the-art neural networks for real-time, automated extraction of insights by triangulating unstructured and structured information from the biomedical literature as well as from l... Read More
